Boudny, M., Zemanova, J., Khirsariya, P., Borsky, M., Verner, J., Cerna, J., Oltova, A., Seda, V., Mraz, M., Jaros, J., Jaskova, Z., Spunarova, M., Brychtova, Y., Soucek, K., Drapela, S., Kasparkova, M., Mayer, J., Paruch, K. and Trbusek, M. (2019) “Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells”, Haematologica. Pavia, Italy, 104(12), pp. 2443-2455. doi: 10.3324/haematol.2018.203430.